Understanding chronic graft-versus-host disease outcomes
Part of Blood & lymphatic, Immune system & allergy clinical trials.
This study follows patients who have had a stem cell transplant and developed chronic graft-versus-host disease (a condition where transplanted cells attack the body). Researchers will track your symptoms and collect blood samples to understand what affects how well patients do over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 1 year or older
- Have been referred by your transplant doctor for evaluation of chronic graft-versus-host disease
- You or your legal representative can provide informed consent
- No life-threatening condition that would prevent you from completing the study
- Not pregnant (if applicable)
- Able to tolerate the study visits and tests
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who are at least 3 years out from their first stem cell transplant to learn how they are doing long term. It may help improve future transplant care by tracking outcomes over time.
This study looks at immune cells in the blood and tissues of people who have had a stem cell transplant. It aims to understand chronic graft-versus-host disease (GVHD), a common complication, so doctors can better detect and treat it.
This study looks at immune cells in tissues affected by chronic graft-versus-host disease (cGVHD), a common complication after a stem cell transplant. It aims to better understand the condition, which may lead to better treatments.
This observational study follows people who had a stem cell transplant a few months ago to better understand risk for chronic graft-versus-host disease. You won’t get a study treatment; instead, you’ll complete questionnaires over time, and the study team looks at your symptoms and experiences.
This study looks at special immune cells in the body that may be involved in graft-versus-host disease (GVHD), a complication after a stem cell transplant. The goal is to better understand these cells to improve future treatments for GVHD.
This study collects blood samples from patients who have survived at least 3 months after a stem cell transplant to identify markers that could predict chronic graft-versus-host disease (a condition where the transplanted cells attack the body). The goal is to develop a simple blood test that could help doctors catch and treat this complication earlier.
Hear when a new Chronic Graft vs. Host Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.